Literature DB >> 11450067

Does an increase in cerebral perfusion pressure always mean a better oxygenated brain? A study in head-injured patients.

J Sahuquillo1, S Amoros, A Santos, M A Poca, H Panzardo, L Domínguez, S Pedraza.   

Abstract

The adequate management of cerebral perfusion pressure (CPP) continues to be a controversial issue in head-injured patients. The purpose of our study was to test two hypotheses. The first was that in patients with a CPP below 70 mm Hg, oxygen delivery is compromised and that therefore signs of tissue hypoxia would be reflected in low PtiO2 measurements. The second hypothesis was that manipulating mean arterial blood pressure to increase CPP improves oxygen delivery, particularly in patients with a CPP below 70 mm Hg. Twenty-five moderately or severely head-injured patients were included in the study. In all of them PtiO2 was monitored in the non-injured hemisphere using the Licox system (GMS, Kiel-Mielkendorf, Germany). Arterial hypertension was induced with phenylephrine 29 times. To quantify the effect of increasing mean arterial blood pressure (MABP) on oxygen delivery to the brain, the PtiO2-BP index was calculated (PtiO2-BP index = delta PtiO2/delta MABP). In 16 tests (55%) baseline CPP was above or equal to 70 mm Hg and in the remaining 13 (45%) it was below 70 mm Hg. Mean increase in MABP after phenylephrine was 23.7 +/- 10.2 mm Hg. Mean PtiO2 was 29.5 +/- 14.7 mm Hg in patients with a basal CPP of below 70 mm Hg and 28.9 +/- 10.6 mm Hg in patients in the high CPP group. These differences being not statistically significant. The PtiO2-BP index was 0.29 +/- 0.23 in patients with a basal CPP of below 70 mm Hg and in patients with a CPP of above 70 mm Hg this index was 0.16 +/- 0.11 Hg. These differences were not statistically significant (Student's t-test, P = 0.09). In our study a low PtiO2 was not observed in patients with marginally low CPPs (48-70 mm Hg) and readings below 15 mm Hg were observed in cases with both normal or supranormal CPPs. We conclude that episodes of low PtiO2 could not be predicted on the basis of CPP alone. On the other hand, raising CPP did not increase oxygen availability in the majority of cases, even if the CPP was markedly improved.

Entities:  

Mesh:

Year:  2000        PMID: 11450067     DOI: 10.1007/978-3-7091-6346-7_95

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  10 in total

1.  Transfusion of erythrocyte concentrates produces a variable increment on cerebral oxygenation in patients with severe traumatic brain injury: a preliminary study.

Authors:  Santiago Ramón Leal-Noval; María Dolores Rincón-Ferrari; Ana Marin-Niebla; Aurelio Cayuela; Victoria Arellano-Orden; Antonio Marín-Caballos; Rosario Amaya-Villar; Carmen Ferrándiz-Millón; Francisco Murillo-Cabeza
Journal:  Intensive Care Med       Date:  2006-09-22       Impact factor: 17.440

2.  Continuous non-invasive optical monitoring of cerebral blood flow and oxidative metabolism after acute brain injury.

Authors:  Wesley B Baker; Ramani Balu; Lian He; Venkaiah C Kavuri; David R Busch; Olivia Amendolia; Francis Quattrone; Suzanne Frangos; Eileen Maloney-Wilensky; Kenneth Abramson; Elizabeth Mahanna Gabrielli; Arjun G Yodh; W Andrew Kofke
Journal:  J Cereb Blood Flow Metab       Date:  2019-05-14       Impact factor: 6.200

3.  Reactivity of brain tissue oxygen to change in cerebral perfusion pressure in head injured patients.

Authors:  Danila K Radolovich; Marek Czosnyka; Ivan Timofeev; Andrea Lavinio; Peter Hutchinson; Arun Gupta; John D Pickard; Peter Smielewski
Journal:  Neurocrit Care       Date:  2009-01-30       Impact factor: 3.210

4.  Cerebral perfusion pressure and risk of brain hypoxia in severe head injury: a prospective observational study.

Authors:  Antonio J Marín-Caballos; Francisco Murillo-Cabezas; Aurelio Cayuela-Domínguez; Jose M Domínguez-Roldán; M Dolores Rincón-Ferrari; Julio Valencia-Anguita; Juan M Flores-Cordero; M Angeles Muñoz-Sánchez
Journal:  Crit Care       Date:  2005-10-14       Impact factor: 9.097

5.  Brain tissue oxygen reactivity: clinical implications and pathophysiology.

Authors:  Gurgen Harutyunyan; Harutyun Mangoyan; Gagik Mkhoyan
Journal:  Front Pharmacol       Date:  2014-05-20       Impact factor: 5.810

6.  New Viewpoint in Exaggerated Increase of PtiO2 With Normobaric Hyperoxygenation and Reasons to Limit Oxygen Use in Neurotrauma Patients.

Authors:  Gurgen Harutyunyan; Garnik Harutyunyan; Gagik Mkhoyan
Journal:  Front Med (Lausanne)       Date:  2018-05-22

Review 7.  Mismatch between Tissue Partial Oxygen Pressure and Near-Infrared Spectroscopy Neuromonitoring of Tissue Respiration in Acute Brain Trauma: The Rationale for Implementing a Multimodal Monitoring Strategy.

Authors:  Mario Forcione; Mario Ganau; Lara Prisco; Antonio Maria Chiarelli; Andrea Bellelli; Antonio Belli; David James Davies
Journal:  Int J Mol Sci       Date:  2021-01-23       Impact factor: 5.923

8.  A Prospective Randomized Study of Brain Tissue Oxygen Pressure-Guided Management in Moderate and Severe Traumatic Brain Injury Patients.

Authors:  Chien-Min Lin; Ming-Chin Lin; Sheng-Jean Huang; Cheng-Kuei Chang; Dan-Ping Chao; Tai-Ngar Lui; Hsin-I Ma; Ming-Ying Liu; Wen-Yuh Chung; Yang-Hsin Shih; Shin-Han Tsai; Hung-Yi Chiou; Mau-Roung Lin; Sen-Li Jen; Li Wei; Chung-Che Wu; En-Yuan Lin; Kuo-Hsing Liao; Yung-Hsiao Chiang; Wen-Ta Chiu; Jia-Wei Lin
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

Review 9.  Current concepts of optimal cerebral perfusion pressure in traumatic brain injury.

Authors:  Hemanshu Prabhakar; Kavita Sandhu; Hemant Bhagat; Padmaja Durga; Rajiv Chawla
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-07

10.  Effect of ephedrine and phenylephrine on brain oxygenation and microcirculation in anaesthetised patients with cerebral tumours: study protocol for a randomised controlled trial.

Authors:  Klaus Ulrik Koch; Anna Tietze; Joel Aanerud; Gorm von Öettingen; Niels Juul; Jens Christian Hedemann Sørensen; Lone Nikolajsen; Leif Østergaard; Mads Rasmussen
Journal:  BMJ Open       Date:  2017-11-17       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.